Faulty Breast Stem Cells May Cause Tumors
Posted on: Wednesday, 4 January 2006, 18:00 CST
WEDNESDAY, Jan. 4 (HealthDay News) -- Defects in a newly identified breast stem cell that drives the formation of breast tissue may lead to tumors, according to an Australian study with mice.
Under normal circumstances, this breast stem cell will produce healthy tissue. But genetic errors in the stem cell, perhaps combined with family predisposition and external factors, could cause the stem cell to produce tumor cells, the researchers said.
This finding may explain cancer recurrence in some women whose breast cancer cells were believed eliminated by chemotherapy. An errant stem cell is more resistant to chemotherapy because it divides more slowly than cancer cells. While chemotherapy may destroy the majority of cancer cells, a defective breast stem cell may survive and begin producing cancer cells months or years after a woman has been treated for breast cancer, said the researchers from the Walter and Eliza Hall Institute.
The researchers are now studying human breast tumors to confirm their findings in mice.
Learning more about this breast stem cell may lead to the development of a drug that can neutralize genetic defects in the stem cell and prevent breast cancer, the researchers said.
The finding appears in the Jan. 5 issue of Nature.
More information
The American Cancer Society has more about breast cancer.
SOURCE: Research Australia, news release, Jan. 4, 2006~-BRS~~GENT~
Source: HealthSCOUT
Related Articles
- Diabetes Drug Kills Cancer Stem Cells
- Drug Compound Discovered That Attacks Cancer Stem Cells
- First Compound That Specifically Kills Cancer Stem Cells Found
- Scientists Discover Bladder Cancer Stem Cell
- Scientists Develop Model That Could Help Identify Cancer Stem Cells
- Researchers Connect Pathway To Breast Cancer Stem Cells
- Finding Breast Cancer Stem Cells In Mice
- NextGen Acquires Patent Application for Breast Cancer Stem Cell Treatment
- Breast Cancer Stem Cells Repressed in Mice
- Somanta Announces Data to Be Presented on Angiolix for Targeting Breast Cancer Stem Cells at Stem Cells and Cancer Conference
User Comments (0)

RSS Feeds